Real-World Healthcare Syndicated
Market Research Solutions
by APLUSA
APLUSA has pioneered the development of syndicated research across numerous therapy areas. Our syndicated studies are designed to provide real-world market insights to multiple clients who purchase a license to access the data and study reports.
Syndicated research at APLUSA delivers real-world based insights (RWD) on a macro or micro level according to your needs. Our expertise in accurately segmenting healthcare markets provides deep, unique datasets and navigates the intricacies of specific markets. Up to 20% of reporting is tailored to the individual client’s requests.
Syndicated studies are the solution for marketers interested in maximizing value for money to obtain strategic and actionable insights, while minimizing the pharmacovigilance burden for the pharmaceutical company.
Navigate through our syndicated offering below, and inquire about specific syndicated research by APLUSA by clicking the button at the bottom of this page.
Real-World Syndicated Healthcare
Market Research Solutions
by APLUSA
APLUSA has pioneered the development of syndicated research across numerous therapy areas. Our syndicated studies are designed to provide real-world market insights to multiple clients who purchase a license to access the data and study reports.
Syndicated research at APLUSA delivers real-world based insights (RWD) on a macro or micro level according to your needs. Our expertise in accurately segmenting healthcare markets provides deep, unique datasets and navigate the intricacies of specific markets. Up to 20% of reporting is tailored to the individual client’s requests.
Syndicated studies are the solution for marketers interested in maximizing value for money to obtain strategic and actionable insights, while minimizing the pharmacovigilance burden for the pharmaceutical company.
Navigate through our syndicated offering below, and inquire about specific syndicated research by APLUSA by clicking the button at the bottom of this page.
Our syndicated offering is based on real-world data (RWD):
- Patient Charts: patients managed by the physician
- Social Media: qualitative and quantitative insights scraped from the web from open data sources
Several purchase options are available:
- Country selection
- Frequency of reporting
- Market segment boost
- Purchase select data only
Why syndicated research?
- Syndicated data collection avoids over-researching small target groups and is cost-efficient
- Our syndicated surveys are based on samples large enough for actionable, country specific findings
- Syndicated research minimizes the AE reporting and compliance burden for the client
Our syndicated offering is based on real-world data (RWD):
- Patient Charts: patients managed by the physician
- Social Media: qualitative and quantitative insights scraped from the web from open data sources
Several purchase options are available:
- Country selection
- Frequency of reporting
- Market segment boost
- Purchase select data only
Why syndicated research?
- Syndicated data collection avoids over-researching small target groups and is cost-efficient
- Our syndicated surveys are based on samples large enough for actionable, country specific findings
- Syndicated research minimizes the AE reporting and compliance burden for the client
Hemato-Oncology
- ALL Acute lymphoblastic leukemia
- AML Acute Myeloid Leukemia
- CAR-T Therapy
- CLL Chronic lymphocytic Leukemia
- CMV infections in transplanted patients
- DLBCL Patient RecordsDiffuse Large B-Cell Lymphoma
- DLBCL Social Media Intelligence
- FL Follicular Lymphoma
- MDS Myelodysplastic syndrome
- MM Multiple Myeloma
- Myelofibrosis
- MZL Marginal Zone Lymphoma
- WM Waldenström macroglobulinemia
Hematology
- Beta-Thalassemia
- Biosimilar vs. Branded in Hematology (Lymphomas DLBCL CLL MCL FL)
- Hemophilia A & B
- ITP Immune Thrombocytopenic purpura
- PNH Paroxysmal nocturnal hemoglobinuria
Oncology
- Bladder Cancer, urothelial carcinoma (m-UC)
- Biosimilar vs. Branded in Oncology (Breast, NSCLC, CRC)
- CMV infections in transplanted patients
- Melanoma
- Mesothelioma
- mRCC Metastatic Renal Cell Carcinoma
- NSCLC Non Small Cell Lung Cancer
- Ovarian cancer
- Prostate Cancer
Immunology
- Asthma Biologics in Severe Asthma
- Atopic Dermatitis
- Biologics Tracker RA – AS – Pso – PsA – UC- Crohn
- Biosimilar vs. Branded in Hematology (Lymphomas DLBCL CLL MCL FL) ; in Inflammation (RA, AS, Pso, PsA, CD, UC); in Oncology (Breast, NSCLC, CRC)
- HAE Hereditary Angioedema
- IBD (Inflammatory Bowel Disease) Ulcerative Colitis and Crohn’s Disease
- IgIV Immunoglobulins in CIDP and MMN Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy
- ScIg subc. immunoglobulins in PID Primary Immunodeficiency
- ITP Immune Thrombocytopenic purpura
dermatology
- Atopic Dermatitis
- Biologics Tracker Pso, PsA
- Biosimilar vs. Branded in Inflammation (Pso, PsA)
- Melanoma
- Psoriasis
gastro-enterology
- IBD UC and Crohn’s Disease
- Biologics Tracker UC-Crohn
- Biosimilar vs. Branded in Inflammation (CD UC)
respiratory
- Heart Failure
- Hypercholesterolemia (HCL)
- PAH Pulmonary Arterial Hypertension
- Migraine
infectiology
dlbcl eBook
Download the APLUSA DLBCL eBook for syndicated market insights and social media listening study in the onco-hematology area.
Let’s talk!
Interested in discovering results from previous waves of one of our syndicated studies, or getting on board for the next one?
Get in touch – we’d be delighted to discuss our syndicated solutions with you.